Clinical Trials Browser

OTHER_GOV × Platinum Compounds × Clear all

NCT07629817 2026-06-05

HCHTOG2603

Phase 3 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT07320105 2026-01-06

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05675033 2023-01-09

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Phase 2 Unknown

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT05569668 2022-10-06

Neoadjuvant Chemotherapy Compared With Surgery for Esophageal Carcinoma

Gastrointestinal

Esophageal Neoplasms